Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination

被引:347
|
作者
Sheaff, RJ
Singer, JD
Swanger, J
Smitherman, M
Roberts, JM
Clurman, BE
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[2] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA
[3] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA
[5] Univ Washington, Dept Med, Seattle, WA 98104 USA
[6] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[7] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA
关键词
D O I
10.1016/S1097-2765(00)80435-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Cdk inhibitor p21(Cip1) is an unstable protein. Pharmacologic inhibition of the proteasome increases the half-life of p21 from less than 30 min to more than 2 hr and results in the accumulation of p21-ubiquitin conjugates. To determine whether ubiquitination was required for proteasomal degradation of p21, we constructed mutant versions of p21 that were not ubiquitinated in vivo. Remarkably, these mutants remained unstable and increased in abundance upon proteasome inhibition, indicating that direct ubiquitination of p21 is not necessary for its turnover by the proteasome. The frequently observed correlation between protein ubiquitination and proteasomal degradation is insufficient to conclude that ubiquitination is a prerequisite for degradation.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 50 条
  • [1] Cytoplasmic localization and ubiquitination of p21Cip1 by reactive oxygen species
    Hwang, Chae Young
    Kim, Ick Young
    Kwon, Ki-Sun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 358 (01) : 219 - 225
  • [2] p21CiP1 restrains pituitary tumor growth
    Chesnokova, Vera
    Zonis, Svetlana
    Kovacs, Kalman
    Ben-Shlomo, Anat
    Wawrowsky, Kolja
    Bannykh, Serguei
    Melmed, Shlomo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (45) : 17498 - 17503
  • [3] Upregulation of p21Cip1 in Activated Glial Cells
    Maria Tusell, Josep
    Ejarque-Ortiz, Aroa
    Mancera, Pilar
    Sola, Carme
    Saura, Josep
    Serratosa, Joan
    GLIA, 2009, 57 (05) : 524 - 534
  • [4] SUMO regulates p21Cip1 intracellular distribution and with p21Cip1 facilitates multiprotein complex formation in the nucleolus upon DNA damage
    Brun, Sonia
    Abella, Neus
    Berciano, Maria T.
    Tapia, Olga
    Jaumot, Montserrat
    Freire, Raimundo
    Lafarga, Miguel
    Agell, Neus
    PLOS ONE, 2017, 12 (06):
  • [5] Expression of p21CIP1/WAF1 in Chondrocytes
    M. C. Stewart
    C. E. Farnum
    J. N. MacLeod
    Calcified Tissue International , 1997, 61 : 199 - 204
  • [6] N-acetylation and ubiquitin-independent proteasomal degradation of p21Cip1
    Chen, XY
    Chi, Y
    Bloecher, A
    Aebersold, R
    Clurman, BE
    Roberts, JM
    MOLECULAR CELL, 2004, 16 (05) : 839 - 847
  • [7] MECHANICAL STRESS INCREASED P21CIP1 EXPRESSION IN CHONDROCYTES
    Hayashi, S.
    Nishiyama, T.
    Takebe, K.
    Kurosaka, M.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S109 - S110
  • [8] The role of PLZF in the transcriptional repression of the p21CIP1 gene
    Choi, Won-Il
    Yoon, Jae-Hyeon
    Hur, Man-Wook
    FASEB JOURNAL, 2010, 24
  • [9] Ubiquitination of p21Cip1/WAF1 by SCFSkp2:: Substrate requirement and ubiquitination site selection
    Wang, W
    Nacusi, L
    Sheaff, RJ
    Liu, XD
    BIOCHEMISTRY, 2005, 44 (44) : 14553 - 14564
  • [10] Degradation of p21cip1 in cells productively infected with human cytomegalovirus
    Chen, ZP
    Knutson, E
    Kurosky, A
    Albrecht, T
    JOURNAL OF VIROLOGY, 2001, 75 (08) : 3613 - 3625